MMP-2 Expression in 102 Patients with Glottic Laryngeal Cancer

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2011 Jun 14

PMID 21667117

Citations 8

Authors

Antony Mallis

Afshin Teymoortash

Nicholas S Mastronikolis

Jochen A Werner

Theodoros A Papadas

Affiliations

Soon will be listed here.

Abstract

In order to evaluate the potential of matrix metalloproteinase 2 (MMP-2) as a prognostic factor for glottic laryngeal cancer. One hundred and two surgical specimens from patients with glottic laryngeal cancer who underwent laryngectomy for their disease in the University Hospital of Patras, Greece from 1998 to 2005 were reviewed retrospectively regarding MMP-2 expression via immunohistochemistry. Immunostaining was performed using a streptavidin-biotin peroxidase complex technique (LSAB). Results revealed that 54 of 102 patients (52.9%) had positive cytoplasmic staining for MMP-2. Kaplan-Meier analysis demonstrated statistically significant difference (p = 0.037) for the 5-year overall survival rate between the groups with positive and negative MMP-2 expression, and marginal statistical significance for the disease free survival rate (p = 0.048). The capsule rupture of metastatic lymph nodes and MMP-2 expression in primary tumor site also seems to be related (p = 0.047). Statistical significance could not be established between MMP-2 expression and the clinicopathological features of the disease (T stage, N stage, clinical stage, differentiation). In conclusion, MMP-2 expression was related with worse overall and disease-free survival and could be considered as a potential marker of poor prognosis.

Citing Articles

Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.

Liutkevicius V, Lesauskaite V, Liutkeviciene R, Vaiciulis P, Uloza V In Vivo. 2019; 34(1):267-274.

PMID: 31882488 PMC: 6984121. DOI: 10.21873/invivo.11770.

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.

Lucas Grzelczyk W, Wrobel-Roztropinski A, Szemraj J, Cybula M, Pietruszewska W, Zielinska-Kazmierska B Arch Med Sci. 2019; 15(3):784-791.

PMID: 31110546 PMC: 6524195. DOI: 10.5114/aoms.2017.72405.

Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.

Hingorani D, Lemieux A, Acevedo J, Glasgow H, Kedarisetty S, Whitney M Oral Oncol. 2017; 71:156-162.

PMID: 28688684 PMC: 5575898. DOI: 10.1016/j.oraloncology.2017.06.009.

Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.

Raju S, Hauff S, Lemieux A, Orosco R, Gross A, Nguyen L Oral Oncol. 2015; 51(5):470-5.

PMID: 25735654 PMC: 4427339. DOI: 10.1016/j.oraloncology.2015.01.014.

Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.

Uloza V, Liutkevicius V, Pangonyte D, Lesauskaite V Clin Exp Otorhinolaryngol. 2015; 8(1):57-64.

PMID: 25729497 PMC: 4338093. DOI: 10.3342/ceo.2015.8.1.57.

References

O-Charoenrat P, Rhys-Evans P, Eccles S . Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001; 127(7):813-20. View

Curran S, Murray G . Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999; 189(3):300-8. DOI: 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C. View

Gorogh T, Beier U, Baumken J, Meyer J, Hoffmann M, Gottschlich S . Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck. 2005; 28(1):31-9. DOI: 10.1002/hed.20298. View

KreCicki T, Zalesska-Krecicka M, Jelen M, Szkudlarek T, Horobiowska M . Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Clin Otolaryngol Allied Sci. 2002; 26(6):469-72. DOI: 10.1046/j.0307-7772.2001.00503.x. View

Xie M, Sun Y, Li Y . Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope. 2004; 114(12):2243-8. DOI: 10.1097/01.mlg.0000149467.18822.59. View

Brasilino de Carvalho M . Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck. 1998; 20(1):16-21. DOI: 10.1002/(sici)1097-0347(199801)20:1<16::aid-hed3>3.0.co;2-6. View

Wiegand S, Dunne A, Muller H, Mandic R, Barth P, Davis R . Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer. 2005; 104(1):94-100. DOI: 10.1002/cncr.21131. View

Danilewicz M, Sikorska B, Wagrowska-Danilewicz M . Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med Sci Monit. 2003; 9(3):MT42-7. View

Chambers A, Matrisian L . Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997; 89(17):1260-70. DOI: 10.1093/jnci/89.17.1260. View

10.

Werner J, Rathcke I, Mandic R . The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis. 2002; 19(4):275-82. DOI: 10.1023/a:1015531319087. View

11.

Burian M, Quint C, Neuchrist C . Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?. Acta Otolaryngol. 1999; 119(2):289-92. DOI: 10.1080/00016489950181846. View

12.

Repassy G, Forster-Horvath C, Juhasz A, Adany R, Tamassy A, Timar J . Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res. 1998; 4(1):14-21. DOI: 10.1007/BF02904689. View

13.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C . Cancer statistics, 2006. CA Cancer J Clin. 2006; 56(2):106-30. DOI: 10.3322/canjclin.56.2.106. View

14.

Almadori G, Bussu F, Paludettii G . Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification. Acta Otorhinolaryngol Ital. 2007; 26(6):326-34. PMC: 2639989. View

15.

Liu W, Zeng Z, Wu Q, Hou J, Chen Y . Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg. 2005; 132(3):395-400. DOI: 10.1016/j.otohns.2004.09.050. View